Search Results

240 results for bmti

BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Surprise! These 3 Dividend Giants Are at 52-Week Lows. Buy Them Before They Soar

By Rich Duprey, InvestorPlace Contributor

Buying dividend giants at 52-week lows is a smart investment strategy to generate the greatest returns when they rebound.

The Top 3 Cannabis Stocks to Buy in April 2024

By Mohammed Saqib, InvestorPlace Contributor

These cannabis stocks are well-positioned to benefit from growth of the cannabis market and provide investors with great returns in April.

3 Dividend Stocks to Buy Now for Lifelong Income

By Yiannis Zourmpanos, InvestorPlace Contributor

Here are three dividend stocks to buy now offering stability, growth, and lifelong income in the pharmaceutical and tobacco industries.

5 Crash-Proof Stocks to Buy Immediately

By Thomas Yeung, CFA, InvestorPlace Markets Analyst

We may not be headed to a full-blown crisis, but savvy investors should protect their portfolios now with these crash-proof stocks.

3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500

By Bob Ciura, Sure Dividend

If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.

BMI Stock Earnings: Badger Meter Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

BMI stock results show that Badger Meter beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

3 Pharma Stocks That Are Money-Printing Machines in 2024

By Michael Que, InvestorPlace Contributor

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

Hidden High-Yielders: 3 Dividend Stocks Everyone’s Overlooking

By Yiannis Zourmpanos, InvestorPlace Contributor

Discover three overlooked dividend stocks offering growth, stability, and unique market niche opportunities for savvy investors.

Riding the Buyback Wave: 3 Must-Own ETFs for 2024

By Julia Magas, InvestorPlace Contributor

Looking to navigate the market more effectively? Here are 3 buyback ETFs with a potential to optimize your investment approach.

These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?

By Rich Duprey, InvestorPlace Contributor

Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

By Muslim Farooque, InvestorPlace Contributor

Capitalize on the biotech sector’s boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments

Wall Street Favorites: 3 Warren Buffett Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor

If you’re wondering where to invest in a stock picker’s market, these three Warren Buffett stocks are a good place to start.

7 Under-The-Radar Growth Stocks to Buy for Multibagger Returns by 2030

By Faisal Humayun, InvestorPlace Contributor

These are the multibagger growth stocks to buy, representing companies positioned for healthy revenue upside through the decade.

Dividend Diamonds in the Rough: 7 Undervalued Income Stocks

By Thomas Niel, InvestorPlace Contributor

High yields and re-rating potential make these the seven best undervalued dividend stocks to buy for strong total returns.

The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today

By Dana Blankenhorn, InvestorPlace Contributor

Vertex hopes Alpine’s drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.

Bearish Blades: 3 Falling Knives to Dodge in 2024

By Steve Booyens, CFA

Numerous stocks are misleading and should be avoided at all costs. Look past stocks like BTI, UPST, and ARR to save your portfolio’s hopes.

BMTX Stock Earnings: BM Technologies Misses EPS, Misses Revenue for Q4 2023

By InvestorPlace Earnings

BMTX stock results show that BM Technologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

By Joey Frenette, InvestorPlace Contributor

The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.

The Bargain Hunter’s Dream: 3 Underpriced Stocks Poised for Massive Gains

By Yiannis Zourmpanos, InvestorPlace Contributor

Three well-known companies stick out among the market’s complexity as excellent chances for investors looking for significant gains.

Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts

By Larry Ramer, InvestorPlace Contributor

With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets. 

The 3 Best Biotech Stocks to Buy in Q2 2024

By Chandler Capital, InvestorPlace Contributor

Biotech can be a risky industry for investors, but we’ve done the legwork for you with these three biotech stocks for Q2.

The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio

By Josh Enomoto, InvestorPlace Contributor

3 Dividend-Boosting Stocks That Could Have More Bumps Ahead

By Steve Booyens, CFA

Dividend-paying stocks don’t always provide sure returns. Stay away from O, BTI, and ESEA to avoid unrealized losses.

2 – 10 of 240 results